Lexeo Therapeutics, Inc.
LX2006
Friedreich Ataxia
Countdown
543days
Approval decision · ~ Jan 1, 2028 estimated
What's at stake
A final FDA approval decision on LX2006 for Friedreich Ataxia is expected ~ Jan 1, 2028.
Primary source
· SEC 8-K
verified 13h ago
“Lexeo expects a BLA submission under the accelerated approval pathway in the first half of 2028.”